Document is current
Any future updates will be listed below
-
Authors
Thuo, Nicholas
Bardon, Ashley R.
Mogere, Peter
Kiptinness, Catherine
Casmir, Edinah
Wairimu, Njeri
Owidi, Emmah
Okello, Phelix
Mugo, Nelly R.
Baeten, Jared M.
Ngure, Kenneth
Ortblad, Katrina F.
-
Funding
Funding for this research was provided by:
U.S. National Institute of Mental Health (R01 MH113572, R01 MH113572)
U.S. National Institutes of Mental Health (R00 MH121166)
- License Information
-
More Information
Article History
Received: 14 May 2024
Accepted: 2 September 2024
First Online: 24 October 2024
Declarations
:
: This research involved human subjects. The research protocol, including all study procedures, was approved by ethics review boards in both the United States (Fred Hutchinson Cancer Center) and Kenya (Scientific Ethics Review Unit, Kenya Medical Research Institute). All eligible participants were enrolled by trained research staff, provided written informed consent, and received 300 KES (~$3 USD) as compensation for their time completing research activities.
: Not applicable.
: JMB is an employee of Gilead Sciences, and PM is an employee of Novartis Pharmaceuticals, both outside this scope of work. For the remaining authors, no competing interests were declared.
